Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Breast biopsy & localization · Florida | Breast biopsy & localization · Texas | |
|---|---|---|
| Surgeons, 2024 | 245 | 203 |
| Medicare fee-for-service cases | 16,085 | 11,818 |
| Growth since 2019 (Medicare FFS) | −0.7%/yr | −2.4%/yr |
| Forecast cases (Medicare FFS) | 18,600 in 2030 | 13,700 in 2030 |
| Forecast growth | +2.5%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.7 | 5.9 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 39% (−3 pts since 2019) | 24% (+0 pts since 2019) |
| Cases per surgeon | 66 | 58 |
| Top 10 surgeons' share | 14% | 16% |
| Surgeons growing | 48 | 34 |
| New since the base year | 48 | 34 |
| Likely to stop billing it | 38 by 2026 | 39 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $4,178 | $3,096 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.